Breaking News Instant updates and real-time market news.

PCRX

Pacira

$33.30

3.8 (12.88%)

07:07
04/09/18
04/09
07:07
04/09/18
07:07

Pacira price target raised to $48 from $45 at H.C. Wainwright

H.C. Wainwright analyst Oren Livnat raised his price target for Pacira Pharmaceuticals to $48 after the FDA approved an additional "narrow" nerve block indication for Exparel. The FDA added a specific interscalene brachial plexus block indication for regional anesthesia, effectively an indication for shoulder replacement or rotator cuff repair, Livnat tells investors in a research note. While a broad general nerve block indication would have been best case, and Pacira has to be careful not to promote off-label, this is still an "important positive," the analyst contends. He reiterates a Buy rating on Pacira shares.

  • 16

    Apr

  • 08

    May

PCRX Pacira
$33.30

3.8 (12.88%)

03/21/18
JEFF
03/21/18
NO CHANGE
Target $49
JEFF
Buy
Pacira shares could be positioned for rebound, says Jefferies
Jefferies analyst David Steinberg believes shares of Pacira Pharmaceuticals could be positioned for a rebound after Symphony Health data indicated Exparel posted "well above trend growth" in February. Sales were $24M, up 3.4% from last month and up 12.6% year-over-year, according to Symphony. The data have shown double digit year-over-years gains in four of the past five months, versus just one of nine months prior, Steinberg tells investors in a research note. He believes Pacira is attractively valued at current levels and keeps a Buy rating on the shares with a $49 price target.
04/06/18
WEDB
04/06/18
NO CHANGE
Target $72
WEDB
Outperform
Wedbush says FDA response for Pacira's EXPAREL in nerve block due
Wedbush analyst Liana Moussatos reiterated an Outperform rating and $72 price target on Pacira Pharmaeuticals ahead of the expected PDUFA date for potential expansion of EXPAREL's label to specify nerve block. In a research note to investors, the analyst said she is "hopeful" that EXPAREL could potentially be used to provide improved outcomes in long-acting regional analgesia compared to infusion pumps or opioids. Whether required post-approval or in preparation for future regulatory review, she sees Pacira to continuing to evaluate EXPAREL in different nerve block techniques.
04/09/18
PIPR
04/09/18
NO CHANGE
Target $44
PIPR
Overweight
Piper reiterates Overweight on Pacira after 'watershed' nerve block approval
FDA approval of Pacira Pharmaceuticals' (PCRX) Exparel as a brachial plexus block "is something of a watershed" in that the agency has never before approved any local or regional anesthetic for a single, specific setting, Piper Jaffray analyst David Amsellem tells investors in a research note. He believes the approval suggests an increasingly aggressive FDA approach towards the opioid crisis. Amsellem points out, however, that feedback from his surgeon survey suggests a "strong degree of enthusiasm" for Heron Therapeutics' (HTRX) HTX-011. However, the feedback also indicates that non-opioid, post-operative pain space is not a zero-sum game, the analyst writes. He believes Exparel can grow "even amid greater competition." Amsellem reiterates an Overweight rating on Pacira with a $44 price target.
04/09/18
JPMS
04/09/18
NO CHANGE
JPMS
Neutral
Pacira nerve block approval a 'clear positive,' at JPMorgan
In a research note partially titled "Something's Better Than Nothing," JPMorgan analyst Chris Schott says Friday night's FDA approval for nerve block is a "clear positive" for Pacira Pharmaceuticals. He notes that the Street broadly expected a Complete Response Letter for Exparel in this indication. While the approval does not include a broad nerve block label, it does allow Pacira to target 1M shoulder blocks performed annually, Schott tells investors. However, the Exparel label update also included several failed nerve block studies that should limit off label use of the drug, the analyst adds. He keeps a Neutral rating on Pacira.

TODAY'S FREE FLY STORIES

OPTN

Optinose

$12.86

-6.64 (-34.05%)

15:28
08/14/18
08/14
15:28
08/14/18
15:28
Recommendations
Optinose analyst commentary  »

Piper not worried by…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Aug

BOOT

Boot Barn

$27.93

1.04 (3.87%)

15:20
08/14/18
08/14
15:20
08/14/18
15:20
Options
Sweep call buyers in Boot Barn as shares lift on heavy volume »

Sweep call buyers in Boot…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Aug

CREE

Cree

$49.94

-0.34 (-0.68%)

15:19
08/14/18
08/14
15:19
08/14/18
15:19
Options
Cree options imply 15.2% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Aug

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

15:17
08/14/18
08/14
15:17
08/14/18
15:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

15:16
08/14/18
08/14
15:16
08/14/18
15:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CSBR

Champions Oncology

$7.80

0.315 (4.21%)

15:12
08/14/18
08/14
15:12
08/14/18
15:12
Conference/Events
Champions Oncology management to meet with Craig-Hallum »

.Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Aug

  • 15

    Aug

GLF

GulfMark Offshore

$38.18

0.48 (1.27%)

15:10
08/14/18
08/14
15:10
08/14/18
15:10
Hot Stocks
Breaking Hot Stocks news story on GulfMark Offshore »

GulfMark Offshore Inc…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$284.02

1.89 (0.67%)

15:06
08/14/18
08/14
15:06
08/14/18
15:06
Technical Analysis
Technical Take: SPDR S&P 500 ETF near session highs in final hour of trading »

The SPDR S&P 500 ETF…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$284.02

1.89 (0.67%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

A

Agilent

$67.01

1.06 (1.61%)

15:04
08/14/18
08/14
15:04
08/14/18
15:04
Options
Agilent options imply 9.7% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Aug

  • 19

    Aug

  • 21

    Aug

CLF

Cleveland-Cliffs

$9.97

-0.235 (-2.30%)

15:00
08/14/18
08/14
15:00
08/14/18
15:00
Options
15K Cleveland Cliffs Aug - Oct 8 call spreads bought for 17c »

15K Cleveland Cliffs Aug…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Sep

15:00
08/14/18
08/14
15:00
08/14/18
15:00
General news
Treasury Closing Summary: »

Treasury Closing Summary:…

WMT

Walmart

$90.90

1.24 (1.38%)

14:59
08/14/18
08/14
14:59
08/14/18
14:59
Hot Stocks
Walmart opens distribution center in Mobile, Alabama »

Walmart commemorated the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Aug

SPR

Spirit AeroSystems

$86.53

-0.23 (-0.27%)

14:57
08/14/18
08/14
14:57
08/14/18
14:57
Hot Stocks
Spirit AeroSystems VP Michelle Lohmeier sells almost $300K in company stock »

Spirit AeroSystems VP…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPOT

Spotify

$193.85

2.4 (1.25%)

, UXIN

Uxin

$5.54

-0.61 (-9.92%)

14:57
08/14/18
08/14
14:57
08/14/18
14:57
Hot Stocks
Tiger Global adds Spotify and Adobe, exits United Continental »

Chase Coleman's…

SPOT

Spotify

$193.85

2.4 (1.25%)

UXIN

Uxin

$5.54

-0.61 (-9.92%)

COUP

Coupa Software

$67.20

1.66 (2.53%)

ADBE

Adobe

$255.81

2.23 (0.88%)

GDS

GDS Holdings

$30.05

-2.58 (-7.91%)

EHIC

eHi Car Services

$12.90

0.05 (0.39%)

ARCC

Ares Capital

$17.37

0.015 (0.09%)

UAL

United Continental

$81.84

0.58 (0.71%)

TWTR

Twitter

$33.04

0.24 (0.73%)

FB

Facebook

$180.91

0.83 (0.46%)

NOW

ServiceNow

$184.66

-0.38 (-0.21%)

MLI

Mueller Industries

$31.95

0.18 (0.57%)

RUN

Sunrun

$12.99

-0.22 (-1.67%)

RDFN

Redfin

$18.04

-0.5 (-2.70%)

JD

JD.com

$33.55

-1.51 (-4.31%)

TDG

TransDigm

$355.86

-0.2 (-0.06%)

MSFT

Microsoft

$109.51

1.27 (1.17%)

AMZN

Amazon.com

$1,915.47

19.96 (1.05%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Aug

  • 16

    Aug

  • 16

    Aug

  • 22

    Aug

  • 22

    Aug

  • 22

    Aug

  • 28

    Aug

  • 04

    Sep

  • 04

    Sep

  • 06

    Sep

  • 07

    Sep

  • 12

    Sep

  • 12

    Sep

  • 13

    Sep

  • 18

    Sep

DENN

Denny's

$14.66

0.12 (0.83%)

14:53
08/14/18
08/14
14:53
08/14/18
14:53
Conference/Events
Denny's participates in a conference call with Stephens »

Conference call with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Aug

  • 16

    Aug

  • 06

    Nov

WPM

Wheaton Precious Metals

$19.94

-0.1 (-0.50%)

14:49
08/14/18
08/14
14:49
08/14/18
14:49
Options
Wheaton Precious Metals options imply 5.1% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Aug

DWSN

Dawson Geophysical

$5.90

0.04 (0.68%)

14:48
08/14/18
08/14
14:48
08/14/18
14:48
Hot Stocks
Dawson Geophysical director William Barrett buys over $100K in stock »

Dawson Geophysical…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$180.92

0.84 (0.47%)

, GOOG

Alphabet

$1,242.00

6.9 (0.56%)

14:48
08/14/18
08/14
14:48
08/14/18
14:48
Conference/Events
William Blair digital media analyst to hold a meeting »

Analysts, along with the…

FB

Facebook

$180.92

0.84 (0.47%)

GOOG

Alphabet

$1,242.00

6.9 (0.56%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Aug

  • 22

    Aug

  • 18

    Sep

  • 20

    Sep

  • 28

    Oct

14:46
08/14/18
08/14
14:46
08/14/18
14:46
Conference/Events
William Blair SaaS analyst to hold a group luncheon »

Software as a Service…

GLF

GulfMark Offshore

$38.18

0.48 (1.27%)

14:45
08/14/18
08/14
14:45
08/14/18
14:45
Hot Stocks
Breaking Hot Stocks news story on GulfMark Offshore »

GulfMark Offshore Inc…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KR

Kroger

$30.38

0.63 (2.12%)

, BABA

Alibaba

$171.94

-5.715 (-3.22%)

14:44
08/14/18
08/14
14:44
08/14/18
14:44
Hot Stocks
Kroger announces pilot for sales in China via Alibaba's Tmall platform »

Kroger (KR) announced a…

KR

Kroger

$30.38

0.63 (2.12%)

BABA

Alibaba

$171.94

-5.715 (-3.22%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Aug

  • 10

    Sep

14:43
08/14/18
08/14
14:43
08/14/18
14:43
Conference/Events
Stephens retail/hardlines analyst to hold luncheon meeting »

Retail/Hardlines Analyst…

TWTR

Twitter

$33.03

0.23 (0.70%)

14:43
08/14/18
08/14
14:43
08/14/18
14:43
Hot Stocks
Twitter suspends accounts for trying to evade account suspension »

Twitter's Safety…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Aug

PLNT

Planet Fitness

$51.74

2.75 (5.61%)

14:40
08/14/18
08/14
14:40
08/14/18
14:40
Options
Bullish flow in Planet Fitness as shares rebound »

Bullish flow in Planet…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PYPL

PayPal

$87.59

0.56 (0.64%)

14:30
08/14/18
08/14
14:30
08/14/18
14:30
Options
Bullish option play opened in Paypal »

Bullish option play…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Aug

  • 15

    Aug

  • 16

    Aug

  • 12

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.